Tennis elbow platelet-rich plasma injection study

2015 ◽  
Author(s):  
Johanna Wales
Keyword(s):  
Tennis Elbow ◽  
Platelet Rich Plasma ◽  
Plasma Injection ◽  
Injection Study

scholarly journals Effects of intralesional platelet-rich plasma in the patients with lateral epicondylitis of elbow

2019 ◽  
Vol 12 (3) ◽  
pp. 138-141
Author(s):  
Mohammad Tariqul Islam ◽  
M. A. Shakoor ◽  
Afsana Mahjabin ◽  
Md. Ali Emran
Keyword(s):  
Visual Analogue Scale ◽  
Daily Living ◽  
Analogue Scale ◽  
Tennis Elbow ◽  
Platelet Rich Plasma ◽  
Lateral Epicondylitis ◽  
Activity Of Daily Living ◽  
Evaluation Tool ◽  
Plasma Injection ◽  
The Difference

Lateral epicondylitis (tennis elbow) is a major cause of musculoskeletal pain involving common extensor origin of the forearm. This study was done to determine the effects of platelet-rich plasma on 15 patients with lateral epicondylitis. Selected patients were given intralesional platelet-rich plasma injection, activity of daily living instructions and paracetamol. Patients were assessed every 14 days interval by visual analogue scale, and the patient rated tennis elbow evaluation. Treatment response according to visual analogue scale and patient rated tennis elbow evaluation tool, the difference of improvement was found in respect to time, from pretreatment W1 (just before 1st Intervention) score to W11 score in every alternate week (p<0.005). This indicates that intralesional platelet-rich plasma is effective in the patients with lateral epicondylitis of elbow.

Results of Platelet Rich Plasma Injection in Chronic Lateral Humeral Epicondylar Tendinopathy

2021 ◽  
Vol 15 (11) ◽  
pp. 3481-3483
Author(s):  
Subhan Shahid ◽  
Muhammad Abubakar ◽  
Rehan Abdul Sattar ◽  
Muhammad Hasan
Keyword(s):  
Pain Relief ◽  
Tennis Elbow ◽  
Platelet Rich Plasma ◽  
Tertiary Care ◽  
Functional Improvement ◽  
Care Hospital ◽  
Effective Treatment Option ◽  
Plasma Injection ◽  
The Mean ◽  
Extensor Carpi Radialis

Background: Lateral humeral epicondylitis or tennis elbow is one of the commonest causes of pain around elbow. Platelet rich plasma is a stimulant for repair in various tendinopathies. Previous studies have suggested platelet rich plasma as a safe & effective treatment option in tennis elbow. Objective: To evaluate the clinical efficacy in terms of relief of pain& functional improvement after PRP injection in patients with chronic tennis elbow. Materials & Method: The trial was conducted in a tertiary care hospital in 70 patients over a period of 2 years.3ml of PRP was injected in & around the Extensor Carpi Radialis Brevis. Pain relief & functional improvement were assessed using visual analogue scale q-DASH scale at 1 month, 3 months, 6 months & 1 year. Results: The mean Nirshl pain score & q-DASH started improving after 02 weeks but significant improvement was seen after 3 months & pain decreased continuously for up to 1 year (p<0.0001). Conclusion: PRP offers a significant pain relief & functional improvement from 3 months to 1 year after injection. Keywords: Lateral epicondylar tendinopathy, platelet rich plasma

Functional outcome of autologous platelet rich plasma injection in plantar fasciitis and tennis elbow

2022 ◽  
Vol 7 (2) ◽  
pp. 76-81
Author(s):  
Rameshwar Sharan Gupta ◽  
Manish Khanna
Keyword(s):  
Repeated Measures ◽  
Plantar Fasciitis ◽  
Tennis Elbow ◽  
Platelet Rich Plasma ◽  
Biological Response ◽  
Osteoblastic Differentiation ◽  
Plasma Injection ◽  
Significant Difference ◽  
Autologous Platelet Rich Plasma ◽  
Autologous Platelet

Recent developments in cellular and molecular biology have emerged as a potent tool in the management of orthopaedic illnesses and injuries. Upon binding to the target cell receptor, the growth factor from platelets triggers the activation of an intracellular signal transduction system, which results in a biological response that is essential for chemotaxis, cell proliferation, and osteoblastic differentiation. The aim of this study is to determine the efficacy and safety of autologous platelet-rich plasma injection in tennis elbow and plantar fasciitis. We conducted a prospective study with patients who were suffering from plantar fasciitis (n=37) or tennis elbow (n=23) and were given with autologous platelet-rich plasma injection. A short term follow up of all these cases were done at regular intervals for 1, 4, 8, and 12 weeks. The clinical outcomes were analyzed with severity of pain and movements of the pathological part. The functional outcomes were analyzed with VAS and AOFAS scoring for plantar fasciitis and VAS and Mayo’s elbow scoring for tennis elbow. All these patients were statistically analyzed by repeated measures ANOVA test. Our investigation found a statistically significant difference between pre-procedural and post-procedural scores in both the subjective (VAS) and functional (AOFAS and Mayo elbow score) grading systems used in this study. Patients who received an autologous platelet-rich plasma injection experienced a statistically significant (p &#60;0.05) improvement in their ability to combat both of the musculoskeletal illnesses studied. Autologous platelet-rich plasma acts as a promising efficacious biological therapeutic agent for use in musculoskeletal disorders such as plantar fasciitis and tennis elbow without major complications upon its usage.

scholarly journals Platelet-rich plasma injection for tennis elbow: did it ever work?

2022 ◽  
Vol 8 (1) ◽  
pp. e001258
Author(s):  
Teemu Karjalainen ◽  
Bethan Richards ◽  
Rachelle Buchbinder
Keyword(s):  
Clinical Trials ◽  
Preparation Method ◽  
Tennis Elbow ◽  
Platelet Rich Plasma ◽  
Cochrane Review ◽  
Clinical Use ◽  
Approval Process ◽  
Plasma Injection ◽  
Phases Of Development ◽  
Better Than

Platelet-rich plasma (PRP) is a commonly used treatment for tendinopathies such as tennis elbow despite the questionable evidence of its efficacy. A recent Cochrane review suggests that it likely does not provide clinically meaningful benefits in people with tennis elbow. In this viewpoint, we discuss how lack of regulation allowed aggressive marketing and clinical use without normal phases of drug development and approval process or rigorous evidence of benefits. Since several phases of development were bypassed, we still do not know the optimal preparation method and dosing of PRP for tendinopathies. Furthermore, several clinical trials compared PRP with other interventions although it was unclear if PRP was better than placebo and these comparisons created distraction rather than improved understanding of its effects.

scholarly journals Management of tennis elbow: a survey of UK clinical practice

2017 ◽  
Vol 11 (3) ◽  
pp. 233-238 ◽  
Author(s):  
Marcus Bateman ◽  
Andrew G. Titchener ◽  
David I. Clark ◽  
Amol A. Tambe
Keyword(s):  
Online Survey ◽  
Tennis Elbow ◽  
Platelet Rich Plasma ◽  
Second Line ◽  
Cross Sectional ◽  
Shockwave Therapy ◽  
Plasma Injection ◽  
Wide Variability ◽  
The Uk ◽  
Corticosteroid Injections

Background Tennis elbow is a common condition in the UK but there are no guidelines on how best to manage the condition. The purpose of the present study was to establish the current UK practice in managing patients with chronic tennis elbow. Methods A cross-sectional online survey of UK surgeons and therapists was conducted in June 2017. Results In total, 275 responses were received, the majority from consultant surgeons and experienced physiotherapists. In total, 81% recommended exercise-based physiotherapy as the first-line intervention. Second-line treatments varied widely, with corticosteroid injections being the most popular (27%), followed by shockwave therapy, platelet-rich plasma injection, surgery, acupuncture and a wait-and-see policy. Conclusions There is wide variability of treatments offered when physiotherapy fails patients with tennis elbow. The majority of second-line interventions lack evidence to support their use and, in the case of corticosteroid injections, may even be harmful in the long term. There is a clear need for national guidance based on best evidence to aid clinicians in their treatment approach.

Sign in / Sign up

Export Citation Format

Share Document